Gyre Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2010
Total Assets: $262.8M
Liabilities Breakdown FY2010
Total Liabilities: $170.9M
Asset Breakdown
Total Assets: $262.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $165.9M | 63.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $149.0K | 0.1% |
| Other Assets | $96.8M | 36.8% |
Liabilities Breakdown
Total Liabilities: $170.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.7M | 2.8% |
| Long-Term Debt | $1.3M | 0.8% |
| Other Liabilities | $164.9M | 96.4% |